Skip to main content
Clinical Trials/NCT02404194
NCT02404194
Completed
N/A

Optimizing Cognitive Training to Improve Functional Outcome in Clinical High Risk (CHR)

Rush University Medical Center1 site in 1 country139 target enrollmentMarch 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Clinical High Risk for Psychosis
Sponsor
Rush University Medical Center
Enrollment
139
Locations
1
Primary Endpoint
Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This project is a randomized-controlled trial to test the efficacy of computer-based targeted cognitive training (TCT) versus a placebo intervention of commercial computer games in adolescent/young adults at clinical high risk (CHR) for psychosis. TCT is designed to optimize learning-induced neuroplasticity in vulnerable neurocognitive systems. A main aim is to test the hypothesis that this neuroscience-guided TCT intervention will improve neural function, and that these neural improvements will improve cognition and functional outcome. CHR participants will be randomly assigned to 40 hours of TCT or placebo computer games completed within 10 weeks. TCT consists of 20 hours of training in cognition, including processing speed, memory, attention, and cognitive control followed by 20 hours of training in social cognition including affect recognition and theory of mind. Neuroimaging, cognition, social cognition, clinical symptoms, and functional status will be assessed at baseline, after 20 hours/5 weeks of cognitive training (mid-intervention), and after 20 hours/5 weeks of social-cognitive training (post-intervention). Cognition, social cognition, symptoms, and functioning will also be assessed at a 9 month follow-up (i.e. 9 months after intervention completion). We predict that TCT will lead to improvements in neurocognitive function and functional status. The results of this study will provide important information about a benign, non-pharmacological intervention for improving cognition and functional outcome in CHR individuals.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
February 15, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christine Hooker

Professor, Department of Psychiatry and Behavioral Sciences

Rush University Medical Center

Eligibility Criteria

Inclusion Criteria

  • English speaking
  • One or more psychosis-risk syndromes as defined by the Structured Interview for Psychosis-Risk Syndromes (SIPS)

Exclusion Criteria

  • Intelligence Quotient (IQ) \< 70
  • Major medical illness or neurological disorder
  • Lifetime history of Axis I psychotic disorder and/or clear evidence that psychosis-risk syndrome is due to non-schizophrenia-spectrum Axis I or Axis II disorder

Outcomes

Primary Outcomes

Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery

Time Frame: Change in cognition from baseline (pre-intervention) to 10 weeks (post-intervention)

Behavioral assessment of cognition

Secondary Outcomes

  • Global Function: Social and Role Scales(Change in functioning from baseline (pre-intervention) to 10 weeks (post-intervention))

Study Sites (1)

Loading locations...

Similar Trials